Investor
Accelmed
1Undisclosed—0
Startups backed by Accelmed that were acquired: 1 exit so far, with the buyer, the price where disclosed and every source.
Image: TailorMedGrowthCurve Capital takes majority control of Israeli medication access startup TailorMed
Israeli business papers valued the deal at about $250 million. Most of TailorMed's venture investors are selling, after the company raised about $60 million since 2016.
Undisclosed$60mStage n/aPrivate equity
Latest in Accelmed
All Accelmed exitsOpen tracker →
GrowthCurve Capital → TailorMedUndisclosedUndisclosed